T. Rowe Price Biotech ETF (TDNA) closed at $24.89 on October 30, 2026, down 1.1% from the previous close, on volume of 447 shares (30-day average 2,127).
Data as of October 30, 2026.
No headlines found.
T. ROWE PRICE DEBUTS BIOTECH, SMALL-CAP, AND MID-CAP EXCHANGE TRADED FUNDS
PRNewswire (Thu, 17-Sep 10:00 AM ET)
T. Rowe Price Biotech ETF trades on the stock market under the symbol TDNA.
As of October 30, 2026, TDNA stock price declined to $24.89 with 447 million shares trading.
TDNA has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
TDNA support price is $24.67 and resistance is $25.67 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TDNA shares will trade within this expected range on the day.
